The little imitator - Porphyria: A neuropsychiatric disorder

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 4, 1997, Pages 319-328

  Crimlisk, Helen L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Metalloporphyrins; Porphyria; Psychosis

Indexed keywords

COPROPORPHYRIN;

ACUTE INTERMITTENT PORPHYRIA; ADULT; CASE REPORT; CLINICAL FEATURE; FEMALE; HETEROZYGOTE DETECTION; HUMAN; MALE; MENTAL DISEASE; MOLECULAR BIOLOGY; PORPHYRIA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; RELAPSE; REVIEW; SCREENING TEST; SKIN DISEASE;

EID: 0030987819     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.4.319     Document Type: Review

References (87)

1. Fischer H, Orth H. Die Chemie des Pyrrols. New York: Johnson Reprint (Leipsig, Akademishce Verlag Güleschaft mbh, 1934), 1968.
2. Massey EW. Neuropsychiatric manifestations of porphyria. J Clin Psychiatry 1980;41:208-13.
3. Waldenström J. Studien über porphyrie. Acta Med Scand 1937;92(suppl):1-24.
4. Elder GH. Molecular genetics of disorders of haem biosynthesis. J Clin Pathol 1993;46:977-81.
5. Hindermarsh JT. Variable phenotypic expression of genotypic abnormalities in the porphyrias. Clin Chim Acta 1993;217:29-38.
6. Nordmann Y, Grandchamp B, de-Verneuil H, et al. Harderoporphyria: a variant hereditary coproporphyria. J Clin Invest 1983;72:1139-49.
7. Kirsch RE, Kordac V. Epidemiology of acute porphyria. Molec Aspects Med 1990;11:39-48.
8. Ben-Chetrit E, Putterman C. Still hazy after all these years. N Engl J Med 1994;331:934-8.
9. Patience DA, Blackwood DHR, McColl KEL, et al. Acute intermittent pophyria and mental illness - a family study. Acta Psychiatr Scand 1994;89:262-7.
10. Stokvis BJ. Over twee zeldsame Kleuerstoffen in Urine van Zieken. Ned Tijdschr Genceskd 1889;13:409-11.
11. Garrod AE. Inborn errors of metabolism. 2nd ed. London: Hodder and Stoughton, 1923.
12. Waldenström J. The porphyrias as inborn errors of metabolism. Am J Med 1957;22:758-72.
13. Dean G. The porphyrias - a story of inheritance and environment, 2nd ed. New York: Lippincott, 1971.
14. Eales L. Porphyrias as seen in Cape Town - a survey of 250 cases and some recent studies. South African Journal of Laboratory Medicine 1963;9:145-51.
15. McAlpine I, Hunter R. The "insanity" of George iii: a classic case of porphyria. BMJ 1966;1:65-71.
16. Jenkins T. The South African malady. Nat Genet 1996;13:7-9.
17. Warren MJ, Jay M, Hunt DM, et al. The maddening business of King George III and porphyria. Trends Biochem Sci 1996;21:229-34.
18. Loftus LS, Arnold WN. Vincent van Gogh's illness: acute intermittent porphyria? BMJ 1991;303:1589-91.
19. Phillips V. Queen Anne's "seventeen disappointments". Med J Aust 1992;156:341-2.
20. Waldenström J. The porphyrias. In: Moore MR, McColl KEL, Rimington C, Goldberg A, eds. Disorders of porphyrin metabolism. New York: Plenum Medical, 1987.
21. Doss M. Acute hepatic porphyrias: a study on 530 cases. Mol Aspects Med 1990;11:44-5.
22. Kordac V, Berman J, Martasek P, et al. Hepatic porphyrias in Czechoslovakia. Mol Aspects Med 1990;11:42.
23. Kappas A, Sassa S, Galbraith RA, et al. The porphyrias: In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The inherited basis of metabolic disorder. New York: McGraw-Hill, 1995.
24. McColl KE, Thompson GG, Moore MR, et al. Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet 1985;ii:796-9.
25. Peters HA, Gocmen A, Cripps DJ, et al. Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years. Arch Neurol 1982;39:744-9.
26. McColl KEL. Therapy of acute porphyria. Mol Aspects Med 1990;11:59-66.
27. Mustajoki P, Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand 1976;200:171-8.
28. Kaelbing R, Craig JB, Passamanick B. Urinary porphobilinogen. Arch Gen Psychiatry 1961;5:494-08.
29. McEwin R, Lawn J, Jonas CT. A survey of porphyria amongst psychiatric patients. Med J Aust 1972;2:302-6.
30. Buttery JE. Is the Watson-Schwartz screening method for porphobilinogen relaible? Clin Chem 1995;41:1670-1.
31. Tishler PV, Woodward B, O'Connor J, et al. High prevalence of acute intermittant porphyria in a psychiatric patient population. Am J Psychiatry 1985;142:1430-6.
32. El-Shazly M. Acute intermittent porphyria: a family study. Br J Hosp Med 1995;53:169-70.
33. Jordan PM, Dailey HA. Biochemistry of porphyrins. Mol Aspects Med 1990;11:21-37.
34. Yeung-Laiwah AC, Moore MR, Goldberg A. Pathogenesis of acute porphyria. Q J Med 1987;63:377-92.
35. Lindberg RL, Porcher C, Grandchamp B, et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 1996;12:195-9.
36. Coskun T, Ozalp I, Kocak N, et al. Type I hereditary tyrosinaemia: presentation of 11 cases. J Inherit Metab Dis 1991;14:765-70.
37. Philip AT, Gerson B. Lead poisoning Part I. Incidence, etiology, and toxicokinetics. Clin Lab Med 1994;14:423-44.
38. Ridley A. Porphyric neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral neuropathy. Philadelphia: Saunders, 1975.
39. Flugel KA, Druschky KF. Electromyogram and nerve conduction in patients with acute intermittent porphyria. J Neurol 1977;214:267-9.
40. Sweeney VP, Pathak MA, Asbury AK. Acute intermittent porphyria. Increased ALA synthetase activity during an acute attack. Brain 1970;93:369-80.
41. Straka JG, Rank JM, Bloomer JR. Porphyria and porphyrin metabolism. Ann Rev Med 1990;41:457-69.
42. Black KS, Mirsky P, Kalina P, et al. Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy. Am J Neuroradiol 1995;16:1650-2.
43. King PH, Bragdon AC. MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria. Neurology 1991;41:1300-3.
44. Thunell S, Andersoson C, Carlmark B, et al. Markers for vulnerability in acute porphyria: a hypothesis paper. Eur J Clin Chem Biochem 1995;33:179-94.
45. Brodie MJ, Goldberg A. Acute hepatic porphyrias. Clin Haematol 1980;9:253-72.
46. Dover SB, Graham A, Moore MR, et al. Lofepramine - a safe antidepressant in acute hepatic porphyria? J Psychopharmacol 1994;8:104-8.
47. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992;71:1-13.
48. Meissner PN, Moore MR, Deybach J. Drugs and porphyria. Mol Aspects Med 1990;11:113-23.
49. British National Formulary. London: BMA, 1996.
50. Thunell S, Floderus Y, Henrichson A, et al. Alcoholic beverages in acute porphyria. J Stud Alcohol 1992;53:272-6.
51. Doss M, Baumann H, Sixel F. Alcohol in acute porphyria. Lancet 1982;i:1 307.
52. Weiland FH, Hellman ES, Gaddis EM, et al. Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. 1. The effects of diet. Metabolism 1964;13:251-8.
53. Lip GYH, McColl KEL, Goldberg A, et al. Smoking and recurrent attacks of acute intermittent porphyria. BMJ 1991;302:507.
54. Boon FFL, Ellis C. Acute intermittent porphyria in a children's psychiatric hospital. J Am Acad Child Adolesc Psychiat 1989;28:606-9.
55. Badcock NR, O'Reilly DA, Zoanetti GD, et al. Childhood porphyrias: implications and treatments. Clin Chem 1993;39:1334-40.
56. Mandoki MW, Sumner GS. Psychiatric manifestations of hereditary coproporphyria in a child. J Nerv Ment Dis 1994;182:117-8.
57. Goldberg A. Acute intermittent porphyria: a study of 50 cases. Q J Med 1959;28:183-209.
58. Stein JA, Tschudy DP. Acute intermittent porphyria: a clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970;49:1-16.
59. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 1993;153:2004-8.
60. Ackner B, Cooper JE, Gray CH, et al. Acute porphyria: a neuropsychiatric and biochemical study. J Psychosom Res 1962;6:1-24.
61. Rijn-van den Meijdenberg JCC, Fekkes D, Wilson JHP, et al. Acute intermittent porphyria and disturbances in amino-acid metabolism in a psychiatric in-patient population. Eur Psychiatry 1994;9:249-53.
62. Carter JH. Updating acute intermittent porphyria: a case of self mutilation. J Natl Med Assoc 1977;69:51-2.
63. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore) 1992;71:1-13.
64. Hardell L, Bengtsson NO, Jonsson U, et al. Aetiological aspects of primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 1984;50:389-97.
65. McEneaney D, Hawkins S, Trimble E, et al. Porphyric neuropathy - a rare and often neglected differential diagnosis of Guillain-Barré syndrome. J Neurol Sci 1993;114: 231-3.
66. Laiwah AC, MacPhee GJ, Boyle P, et al. Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry 1985;45:1025-30.
67. Vassallo MJ, Camilleri M, Sullivan SN, et al. Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol 1992;14: 255-9.
68. Scane AC, Wight JP, Godwin-Austin RB. Acute intermittent porphyria presenting as epilepsy. BMJ 1986;292: 946-7.
69. Bylesjö I, Forsgren L, Lithner F, et al. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia 1996;37:230-5.
70. Downey DC. Fatigue syndromes revisited: the possible role of porphyrins. Med Hypotheses 1994;42:285-90.
71. Bondowsky HL. Advances in understanding and treating "the little imitator", acute porphyria. Gastroenterology 1995;105:590-4.
72. Procter A, McKenzie IP. Opiate dependence in acute intermittent porphyria. Irish Journal of Psychological Medicine 1994;11:133-4.
73. Santosh PJ, Malhotra S. Varied psychiatric manifestations of acute intermittent porphyria. Biol Psychiatry 1994;36: 744-7.
74. Reynolds NC, Miska RM. Safety of anticonvulsants in hepatic porphyrias. Neurology 1981;31:480-4.
75. Gregor A, Kostrzewska E, Tarczynska-Nosal S, et al. Coexistence of hereditary coproporphyria with acute intermittent porphyria. Ann Med 1994;26:125-7.
76. Grandchamp B, De Verneuil H, Beaumont C, et al. Tissue-specific expression of porphobilinogen deaminase: two isoenzymes from a single gene. Eur J Biochem 1987;162: 105-10.
77. Whatley SD, Roberts AG, Elder GH. De-novo mutation and sporadic presentation of acute intermittent porphyria. Lancet 1995;246:1007-8.
78. Meissner PN, Dailey TA, Hift RJ, et al. A R59W mutation in human protoporphrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet 1996;13:95-6.
79. Ratnaike S, Blake D. The diagnosis and follow up of porphyria. Pathology 1995;27:142-53.
80. Pinkham JM, Southall DP. Unusual case of suspected acute porphyria. Clin Chem 1995;41:323-4.
81. Lim CK, Peters TJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta 1984;139:55-63.
82. Deacon AC. Faecal porphyrin screening. Clin Chem 1990; 36:1383.
83. Logan GM, Weimer MK, Ellefson M, et al. Bile porphyrin analysis in the evaluation of variegate porphyria. N Engl J Med 1991;324:1408-11.
84. Pierach CA, Weimer MK, Cardinal RA, et al. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria. JAMA 1987;257:60-1.
85. Mustajoki P, Tenhunen R. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity. Eur J Clin Invest 1985;15:281-4.
86. Herrick AL, McColl KEL, Moore MR, et al. Controlled trial of haem arginate in acute hepatic porphyria. Lancet 1989;i:1295-7.
87. Herrick AL, McColl KEL, Wallace AM, et al. LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria. Q J Med 1990;276:355-63.